Konsensuspapier zur Prophylaxe der RSV-Infektion mit Palivizumab und Post-RSV-Atemwegserkrankung
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery,Pediatrics, Perinatology and Child Health
Link
http://link.springer.com/content/pdf/10.1007/s00112-008-1722-y.pdf
Reference52 articles.
1. Abman SH, Ogle JW, Butler-Simon N et al. (1988) Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr 113: 826–830
2. Arnold SR, Wang EE, Law BJ et al. (1999) Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J 18: 866–869
3. Boeckh M, Berrey MM, Bowden RA et al. (2001) Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis 184: 350–354
4. Bont L, Steijn M, Van Aalderen WMC et al. (2004) Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection. Thorax 59: 512–516
5. Bramley AM, Vitalis TZ, Wiggs BR et al. (1999) Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs. Eur Respir J 14: 1061–1067
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Systematic Review of European Clinical Practice Guidelines for Respiratory Syncytial Virus Prophylaxis;The Journal of Infectious Diseases;2022-03-25
2. Respiratory-Syncytial-Virus-Prophylaxe mit Palivizumab;Pädiatrie & Pädologie;2019-11-12
3. Respiratory Syncytial Virus Infections among Children with Congenital Heart Disease;The Burden of Respiratory Syncytial Virus Infection in the Young;2019-10-30
4. Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI);PLOS ONE;2016-06-16
5. Prophylaxe von schweren RSV-Erkrankungen bei Risikokindern mit Palivizumab (S2);Leitlinien Kinder- und Jugendmedizin;2015
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3